Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prioritizing polio.
Rath B, Ali M, Elemuwa C, Maurer W, Bouder F, Mworozi E, Diedrich S, Khamesipour A, Chitwood I, Kochhar S; Vienna Vaccine Safety Initiative. Rath B, et al. Among authors: khamesipour a. Expert Rev Vaccines. 2012 Dec;11(12):1389-92. doi: 10.1586/erv.12.128. Expert Rev Vaccines. 2012. PMID: 23252381 No abstract available.
Introducing new vaccines in developing countries.
Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M; Vienna Vaccine Safety Initiative. Kochhar S, et al. Among authors: khamesipour a. Expert Rev Vaccines. 2013 Dec;12(12):1465-78. doi: 10.1586/14760584.2013.855612. Expert Rev Vaccines. 2013. PMID: 24195483 Review.
The importance of the patient voice in vaccination and vaccine safety-are we listening?
Holt D, Bouder F, Elemuwa C, Gaedicke G, Khamesipour A, Kisler B, Kochhar S, Kutalek R, Maurer W, Obermeier P, Seeber L, Trusko B, Gould S, Rath B. Holt D, et al. Among authors: khamesipour a. Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S146-S153. doi: 10.1016/j.cmi.2016.09.027. Epub 2016 Dec 6. Clin Microbiol Infect. 2016. PMID: 27939015 Free article.
Safety reporting in developing country vaccine clinical trials-a systematic review.
Muehlhans S, Richard G, Ali M, Codarini G, Elemuwa C, Khamesipour A, Maurer W, Mworozi E, Kochhar S, Rundblad G, Vuitton D, Rath B. Muehlhans S, et al. Among authors: khamesipour a. Vaccine. 2012 May 9;30(22):3255-65. doi: 10.1016/j.vaccine.2012.02.059. Epub 2012 Mar 7. Vaccine. 2012. PMID: 22406279 Review.
Template protocol for clinical trials investigating vaccines--focus on safety elements.
Bonhoeffer J, Imoukhuede EB, Aldrovandi G, Bachtiar NS, Chan ES, Chang S, Chen RT, Fernandopulle R, Goldenthal KL, Heffelfinger JD, Hossain S, Jevaji I, Khamesipour A, Kochhar S, Makhene M, Malkin E, Nalin D, Prevots R, Ramasamy R, Sellers S, Vekemans J, Walker KB, Wilson P, Wong V, Zaman K, Heininger U; Brighton Collaboration Clinical Trial Protocol Working Group. Bonhoeffer J, et al. Among authors: khamesipour a. Vaccine. 2013 Nov 12;31(47):5602-20. doi: 10.1016/j.vaccine.2013.02.041. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499603 Free PMC article.
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Rüggeberg JU, Gold MS, Bayas JM, Blum MD, Bonhoeffer J, Friedlander S, de Souza Brito G, Heininger U, Imoukhuede B, Khamesipour A, Erlewyn-Lajeunesse M, Martin S, Mäkelä M, Nell P, Pool V, Simpson N; Brighton Collaboration Anaphylaxis Working Group. Rüggeberg JU, et al. Among authors: khamesipour a. Vaccine. 2007 Aug 1;25(31):5675-84. doi: 10.1016/j.vaccine.2007.02.064. Epub 2007 Mar 12. Vaccine. 2007. PMID: 17448577 No abstract available.
First generation leishmaniasis vaccines: a review of field efficacy trials.
Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. Noazin S, et al. Among authors: khamesipour a. Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23. Vaccine. 2008. PMID: 18950671 Review.
223 results